Bristol Myers Squibb Announces Data from EXPLORER-LTE Demonstrating Sustained Improvements in Clinically Meaningful Cardiovascular Outcomes at Weeks 48 and 84 in Patients with Symptomatic Obstructive Hypertrophic Cardiomyopathy Receiving Mavacamten

On April 3, 2022

Notice: ob_end_flush(): failed to send buffer of zlib output compression (0) in /home/biznews/public_html/wp-includes/functions.php on line 5219

Related Post

Duke Energy offers tips, tools to help customers save energy, money as temperatures rise

S&P Colombia Select Index Consultation on Eligibility Criteria and Index Construction

S&P Equal Sector ESG Select Equal Weight Indices Methodology